[N-benzyl-N'-methoxycarbonyl-hydrazino]-acetic acid | 870889-69-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [N-benzyl-N'-methoxycarbonyl-hydrazino]-acetic acid
• 英文别名: Nβ-Moc-Nα-benzyl-hydrazinoglycine；2-[benzyl-(methoxycarbonylamino)amino]acetic acid
• CAS: 870889-69-3
• 化学式: C₁₁H₁₄N₂O₄
• 分子量: 238.243
• InChiKey: VWABRNACBGNQNC-UHFFFAOYSA-N

物化性质

• 密度：
  1.281±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.84
• 重原子数：
  17.0
• 可旋转键数：
  5.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  78.87
• 氢给体数：
  2.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  [N-benzyl-N'-methoxycarbonyl-hydrazino]-acetic acid 在 哌啶 、 1-羟基苯并三唑 、 N,N'-二异丙基碳二亚胺 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 3.13h， 生成 (5-{2-fluoro-4-[(5R)-2-oxo-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-3-yl]phenyl}pyridin-2-yl)methyl imidothiocarbamate
  参考文献：
  名称：

  [EN] REVERSE-TURN MIMETICS AND METHOD RELATING THERETO
  [FR] MIMETIQUES A ROTATION INVERSE ET PROCEDE ASSOCIE

  摘要：

  公开号：

  WO2005116032A3
• 作为产物：
  描述：

  [N-benzyl-N'-methoxycarbonyl-hydrazino]-acetic acid ethyl ester 在 sodium hydroxide 、 水 、 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 2.0h， 生成 [N-benzyl-N'-methoxycarbonyl-hydrazino]-acetic acid
  参考文献：
  名称：

  [EN] REVERSE-TURN MIMETICS AND METHOD RELATING THERETO
  [FR] MIMETIQUES A ROTATION INVERSE ET PROCEDE ASSOCIE

  摘要：

  公开号：

  WO2005116032A3

文献信息

• [EN] MODULATION OF beta-CATENIN/TCF ACTIVATED TRANSCRIPTION<br/>[FR] MODULATION DE LA TRANSCRIPTION ACTIVEE PAR <supplemental>20050707</supplemental>WO03031448A1CHOONGWAE PHARMA CORP [KR]20030417WDX1-21,23-32,39-49,54,55Y51-53,55DXYHECHT ANDREAS ET AL: "The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 19, no. 8, 17 April 2000 (2000-04-17), pages 1839 - 1850, XP001205223, ISSN: 0261-4189HECHT ANDREAS ET ALThe p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebratesEMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL200004171980261-418918391850WX48,50,58-69Y1-33,49,51XYMORIN P J ET AL: "Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 275, 21 March 1997 (1997-03-21), pages 1787 - 1790, XP002088507, ISSN: 0036-8075MORIN P J ET ALActivation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APCSCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US199703212750036-807517871790WY1-33YOVING I M ET AL: "Molecular causes of colon cancer", EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, BLACKWELL SCIENTIFIC PUBLICATIONS, XX, vol. 32, no. 6, June 2002 (2002-06-01), pages 448 - 457, XP002265366, ISSN: 0014-2972OVING I M ET ALMolecular causes of colon cancerEUROPEAN JOURNAL OF CLINICAL INVESTIGATION, BLACKWELL SCIENTIFIC PUBLICATIONS, XX2002063260014-2972448457WYD1-33YDTAKEMARU K-I ET AL: "THE TRANSCRIPTIONAL COACTIVATOR CBP INTERACTS WITH BETA-CATENIN TO ACTIVATE GENE EXPRESSION", THE JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, US, vol. 149, no. 2, 17 April 2000 (2000-04-17), pages 249 - 254, XP001063381, ISSN: 0021-9525TAKEMARU K-I ET ALTHE TRANSCRIPTIONAL COACTIVATOR CBP INTERACTS WITH BETA-CATENIN TO ACTIVATE GENE EXPRESSIONTHE JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, US2000041714920021-9525249254WX48Y1-33,49,51XYMORIN P J: "beta-catenin signaling and cancer", BIOESSAYS, CAMBRIDGE, GB, vol. 21, December 1999 (1999-12-01), pages 1021 - 1030, XP002174509, ISSN: 0265-9247MORIN P Jbeta-catenin signaling and cancerBIOESSAYS, CAMBRIDGE, GB199912210265-924710211030WY1-33,52,53YUS6762185B1KAHN MICHAEL [US], et al20040713WDPX1-33PY38DPXPYUS2004072831A1MOON SUNG HWAN [KR], et al20040415WDPX1-21,23-32PY38DPXPYEMAMI KATAYOON H ET AL: "A small molecule inhibitor of beta-catenin/cyclic AMP response element-binding protein transcription", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 101, no. 34, 24 August 2004 (2004-08-24), pages 12682 - 12687, XP002317529, ISSN: 0027-8424EMAMI KATAYOON H ET ALA small molecule inhibitor of beta-catenin/cyclic AMP response element-binding protein transcriptionPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA20040824101340027-84241268212687WPX1-33PXDANIELS D L ET AL: "beta-catenin: molecular plasticity and drug design", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 26, no. 11, 1 November 2001 (2001-11-01), pages 672 - 678, XP004326488, ISSN: 0968-0004DANIELS D L ET ALbeta-catenin: molecular plasticity and drug designTIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN2001110126110968-0004672678WA1-33AHEDGEPETH C M ET AL: "Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.", DEVELOPMENTAL BIOLOGY. 1 MAY 1997, vol. 185, no. 1, 1 May 1997 (1997-05-01), pages 82 - 91, XP002326326, ISSN: 0012-1606HEDGEPETH C M ET ALActivation of the Wnt signaling pathway: a molecular mechanism for lithium action.DEVELOPMENTAL BIOLOGY. 1 MAY 19971997050118510012-16068291WX34-37XKLEIN P S ET AL: "A molecular mechanism for the effect of lithium on development.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 6 AUG 1996, vol. 93, no. 16, 6 August 1996 (1996-08-06), pages 8455 - 8459, XP002326327, ISSN: 0027-8424KLEIN P S ET ALA molecular mechanism for the effect of lithium on development.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 6 AUG 19961996080693160027-842484558459AX34,37XSTAAL F J T ET AL: "WNT SIGNALS ARE TRANSMITTED THROUGH N-TERMINALLY DEPHOSPHORYLATED BETA-CATENIN", EMBO REPORTS, vol. 3, no. 1, January 2002 (2002-01-01), pages 63 - 68, XP001205224STAAL F J T ET ALWNT SIGNALS ARE TRANSMITTED THROUGH N-TERMINALLY DEPHOSPHORYLATED BETA-CATENINEMBO REPORTS20020131636863R364L165L2R2366L2X34-37Y38XYWODARZ A ET AL: "MECHANISMS OF WNT SIGNALING IN DEVELOPMENT", ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, ANNUAL REVIEWS, PALO ALTO, CA, US, vol. 14, 1988, pages 59 - 88, XP001012698, ISSN: 1081-0706WODARZ A ET ALMECHANISMS OF WNT SIGNALING IN DEVELOPMENTANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, ANNUAL REVIEWS, PALO ALTO, CA, US1988141081-07065988A792803X34-37Y38XYNELSON W JAMES ET AL: "Convergence of Wnt, beta-catenin, and cadherin pathways.", SCIENCE. 5 MAR 2004, vol. 303, no. 5663, 5 March 2004 (2004-03-05), pages 1483 - 1487, XP002326328, ISSN: 1095-9203NELSON W JAMES ET ALConvergence of Wnt, beta-catenin, and cadherin pathways.SCIENCE. 5 MAR 20042004030530356631095-920314831487WPX34-37,39-41PXLÉVY LAURENCE ET AL: "Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.", MOLECULAR AND CELLULAR BIOLOGY. APR 2004, vol. 24, no. 8, April 2004 (2004-04-01), pages 3404 - 3414, XP002326329, ISSN: 0270-7306LÉVY LAURENCE ET ALAcetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.MOLECULAR AND CELLULAR BIOLOGY. APR 20042004042480270-730634043414WPX48,50PY49,51PXPYMIYAGISHI M ET AL: "Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 10 NOV 2000, vol. 275, no. 45, 10 November 2000 (2000-11-10), pages 35170 - 35175, XP002326330, ISSN: 0021-9258MIYAGISHI M ET ALRegulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300.THE JOURNAL OF BIOLOGICAL CHEMISTRY. 10 NOV 200020001110275450021-92583517035175X48,50Y49,51XYGUSTERSON ROSALIND J ET AL: "The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 28 FEB 2003, vol. 278, no. 9, 28 February 2003 (2003-02-28), pages 6838 - 6847, XP002326331, ISSN: 0021-9258GUSTERSON ROSALIND J ET ALThe transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity.THE JOURNAL OF BIOLOGICAL CHEMISTRY. 28 FEB 20032003022827890021-925868386847WDX48,50DXEP1054059A1VLAAMS INTERUNIV INST BIOTECH [BE]20001122WX52XCOWIN P: "Unraveling the cytoplasmic interactions of the cadherin superfamily.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 8 NOV 1994, vol. 91, no. 23, 8 November 1994 (1994-11-08), pages 10759 - 10761, XP002326332, ISSN: 0027-8424COWIN PUnraveling the cytoplasmic interactions of the cadherin superfamily.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 8 NOV 19941994110891230027-84241075910761WY52,53YMUNEMITSU SUSAN ET AL: "Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, no. 7, 1995, pages 3046 - 3050, XP002160048, ISSN: 0027-8424MUNEMITSU SUSAN ET ALRegulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor proteinPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US19959270027-842430463050WX52,54Y53,55XYFILIPAK M ET AL: "Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation", MEDLINE ABSTRACT, JOURNAL OF CELLULAR PHYSIOLOGY, vol. 137, no. 2, 1988, XP002904585FILIPAK M ET ALTumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiationMEDLINE ABSTRACT, JOURNAL OF CELLULAR PHYSIOLOGY19881372WX56XKIELMAN M F ET AL: "Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling", NATURE GENETICS, NATURE AMERICA, NEW YORK, US, vol. 32, no. 4, 20 December 2002 (2002-12-20), pages 594 - 605, XP002233454, ISSN: 1061-4036KIELMAN M F ET ALApc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signalingNATURE GENETICS, NATURE AMERICA, NEW YORK, US200212203241061-4036594605WX56XWO03068961A2AXORDIA LTD [GB], et al20030821the whole document, but see especially SEQ. ID NO 49 (for SEQ: ID NO 1 as claimed) and SEQ ID NO 2 (for SEQ ID NO 3 as claimed)X70-79,90-96,104-110,116-127,138-144,152-158XUS6063583AMONTMINY MARC R [US]20000516col. 13-30X70-79,90-96,104-110XWO9918124A1MERCK & CO INC [US], et al19990415Wsee esp. Fig. 7aX80-89,97-103,111-117XPATENT ABSTRACTS OF JAPAN vol. 1999, no. 05 31 May 1999 (1999-05-31)PATENT ABSTRACTS OF JAPAN19990531199905JPH1132767AAClaim 3, pp. 13-14, Seq. with 567 amino acidsX80-89,97-103,111-117,128-137,145-151,159-165XWO02065134A2UNIV DUNDEE [GB], et al20020822claim 9, SEQ: ID NO 9X80-89,97-103,111-117XWO9803652A2US HEALTH [US], et al19980129see the whole document. Specifically, Seq ID NO 3 and Seq. ID NO 9, also claims 1-16X80-89,97-103,111-117,128-137,145-151,159-165XEP1302104A1CHUGAI PHARMACEUTICAL CO LTD [JP], et al20030416seq. ID No. 1, example 1X128-137,145-151,159-165X
  申请人：CHOONGWAE PHARMA CORP

  公开号：WO2005021025A3

  公开（公告）日：2005-07-07
• [EN] REVERSE-TURN MIMETICS AND METHOD RELATING THERETO<br/>[FR] MIMETIQUES A ROTATION INVERSE ET PROCEDE ASSOCIE
  申请人：CHOONGWAE PHARMA CORP

  公开号：WO2005116032A3

  公开（公告）日：2006-04-13